WM

William Markland

DY Dyax: 20 patents #4 of 129Top 4%
VI Vertex Pharmaceuticals Incorporated: 4 patents #369 of 896Top 45%
PE Protein Engineering: 3 patents #5 of 6Top 85%
AT Atmel: 1 patents #459 of 762Top 65%
Overall (All Time): #136,299 of 4,157,543Top 4%
28
Patents All Time

Issued Patents All Time

Showing 25 most recent of 28 patents

Patent #TitleCo-InventorsDate
11980633 Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors Diane Boucher, Shawn Hillier, Wanjung Tsai, Brian Hare, David A. Newsome +1 more 2024-05-14
11110108 Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors Diane Boucher, Shawn Hillier, Wanjung Tsai, Brian Hare, David A. Newsome +1 more 2021-09-07
8663629 Kallikrein-binding “kunitz domain” proteins and analogues thereof Robert Charles Ladner 2014-03-04
8431359 Nucleic acids encoding polypeptide inhibitors of human plasmin derived from the Kunitz domains Robert Charles Ladner 2013-04-30
8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof Robert Charles Ladner 2012-10-09
8002891 Crystallization of C-Jun N-Terminal Kinase 3 (JNK3) Xiaoling Xie, Yong Gu, Michael Su, Paul R. Caron, Edward J. Fox +1 more 2011-08-23
7919462 Inhibitors of human plasmin derived from the Kunitz domains Robert Charles Ladner 2011-04-05
7893007 Directed evolution of novel binding proteins Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent 2011-02-22
7628983 Kallikrein-binding “Kunitz domain” proteins and analogues thereof Robert Charles Ladner 2009-12-08
7413537 Directed evolution of disulfide-bonded micro-proteins Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent 2008-08-19
7383135 Methods of designing inhibitors for JNK kinases Xiaoling Xie, Yong Gu, Michael Su, Paul R. Caron, Edward J. Fox +1 more 2008-06-03
7256094 Method for changing threshold voltage of device in resist asher Chungdar Daniel Wang 2007-08-14
7208293 Directed evolution of novel binding proteins Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent 2007-04-24
7118879 Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent 2006-10-10
7078383 ITI-D1 Kunitz domain mutants as HNE inhibitors Arthur C. Ley, Sonia Guterman, Rachel Kent, Bruce Lindsay Roberts, Robert Charles Ladner 2006-07-18
6979538 Directed evolution of novel binding proteins Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent 2005-12-27
6953674 Inhibitors of human plasmin derived from the kunitz domains Robert Charles Ladner 2005-10-11
6423498 Variegated Kunitz domain peptide library and uses thereof Robert Charles Ladner 2002-07-23
6333402 "Kallikrein-binding ""Kunitz domain"" proteins and analogues thereof" Robert Charles Ladner 2001-12-25
6103499 Inhibitors of human plasmin derived from the Kunitz domains Robert Charles Ladner 2000-08-15
6071723 Inhibitors of human plasmin derived from the Kunitz domains Robert Charles Ladner 2000-06-06
6057287 "Kallikrein-binding ""Kunitz domain"" proteins and analogues thereof" Robert Charles Ladner 2000-05-02
6010880 Inhibitors of human plasmin derived from the kunitz domains Robert Charles Ladner 2000-01-04
5837500 Directed evolution of novel binding proteins Robert Charles Ladner, Sonia Kosow Gutterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent 1998-11-17
5663143 Engineered human-derived kunitz domains that inhibit human neutrophil elastase Arthur C. Ley, Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Rachel Kent 1997-09-02